The Scientist

» clinical trials and immunology

Most Recent

image: Why So Soon?

Why So Soon?

By | May 1, 2013

Researchers are using modern experimental tools to probe the mysterious molecular pathways that lead to premature labor and birth.

4 Comments

image: Building a Better Network

Building a Better Network

By | April 23, 2013

NIH Director Francis Collins and colleagues announce plans to create a health-care research network to connect patients, doctors, and clinical researchers.

0 Comments

image: Virus Versus Bacteria

Virus Versus Bacteria

By | April 17, 2013

A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.

1 Comment

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Contributors

Contributors

By | April 1, 2013

Meet some of the people featured in the April 2013 issue of The Scientist.

0 Comments

image: Making Cancer More Transparent

Making Cancer More Transparent

By | April 1, 2013

A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.

3 Comments

image: Mimicking Mussels

Mimicking Mussels

By | April 1, 2013

Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.

1 Comment

image: Clinical Trial Transparency in Europe?

Clinical Trial Transparency in Europe?

By | March 28, 2013

The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Classic Example of Symbiosis Revised
  3. The Genetic Components of Rare Diseases
  4. Orangutan Imitates Human Speech
RayBiotech